A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice
about
BALB/c mice immunized with a combination of virus-like particles incorporating Kaposi sarcoma-associated herpesvirus (KSHV) envelope glycoproteins gpK8.1, gB, and gH/gL induced comparable serum neutralizing antibody activity to UV-inactivated KSHV.Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice.Designing an effective vaccine to prevent Epstein-Barr virus-associated diseases: challenges and opportunities.Expression and immunogenic characterization of recombinant gp350 for developing a subunit vaccine against Epstein-Barr virus.Virus like particles as a platform for cancer vaccine development.Immunization With Fc-Based Recombinant Epstein-Barr Virus gp350 Elicits Potent Neutralizing Humoral Immune Response in a BALB/c Mice Model.
P2860
A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
A chimeric EBV gp350/220-based ...... eutralizing antibodies in mice
@en
type
label
A chimeric EBV gp350/220-based ...... eutralizing antibodies in mice
@en
prefLabel
A chimeric EBV gp350/220-based ...... eutralizing antibodies in mice
@en
P2093
P2860
P1476
A chimeric EBV gp350/220-based ...... eutralizing antibodies in mice
@en
P2093
Agapi Parcharidou
Deep Agnani
Javier Gordon Ogembo
Joyce D Fingeroth
Juan Avendano
Lori W McGinnes
Matthew R Muraswki
Robert W Finberg
Rujapak Sutiwisesak
Timelia Tison
P2860
P2888
P356
10.1186/S12967-015-0415-2
P577
2015-02-06T00:00:00Z
P5875
P6179
1030670394